Title:
ヒト化抗CD47抗体
Document Type and Number:
Japanese Patent JP4637749
Kind Code:
B2
Abstract:
The present invention relates to humanized antibodies binding to CD47; diabodies binding to human CD47, characterized in that a disulfide bond exists between diabody-forming fragments; genes encoding any one of said antibodies; vectors containing said genes; host cells containing said vectors; processes for preparing antibodies comprising the step of culturing said host cells; and therapeutic agents for hematological disorders comprising said antibodies.
More Like This:
WO/2022/096896 | MYCOBACTERIAL IMMUNOTHERAPY FOR TREATING CANCER |
WO/2016/094309 | INHIBITION OF TNF SIGNALING IN CANCER IMMUNOTHERAPY |
WO/2017/134134 | BCMA and CD3 Bispecific T Cell Engaging Antibody Constructs |
Inventors:
Yasufumi Kikuchi
Shinsuke Uno
Kyoko Kinoshita
Nariyuki Iijima
Nao Fukushima
Masayuki Tsuchiya
Shinsuke Uno
Kyoko Kinoshita
Nariyuki Iijima
Nao Fukushima
Masayuki Tsuchiya
Application Number:
JP2005515369A
Publication Date:
February 23, 2011
Filing Date:
November 11, 2004
Export Citation:
Assignee:
Chugai Pharmaceutical Co., Ltd.
International Classes:
C07K16/28; A61K39/395; A61P7/00; A61P7/06; A61P35/00; A61P35/02; C12N5/10; C12N15/09; C12P21/08
Domestic Patent References:
JP4502408A | ||||
JP8217799A | ||||
JP11092500A |
Foreign References:
WO1999012973A1 | ||||
WO2000053634A1 |
Attorney, Agent or Firm:
Kazuo Shamoto
Shinjiro Ono
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Hiroko Ejiri
Shinjiro Ono
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Hiroko Ejiri